
Israel's largest healthcare provider is reporting a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.
Megan Revell reports.
Israel's largest healthcare provider is reporting a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.
Megan Revell reports.